Literature DB >> 27512314

Secret in the eyes - fish eye disease.

V K Ingle1, P K Maharana2, P Rajesh2.   

Abstract

Entities:  

Year:  2016        PMID: 27512314      PMCID: PMC4964702          DOI: 10.4103/0971-4065.179304

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN: 0971-4065


× No keyword cloud information.
Sir, In response to “Co-existence of classic familial lecithin-cholesterol acyltransferase deficiency and fish eye disease in the same family”,[1] we would like to report a case of Fish eye disease. A 42-year-old male was referred for physician consultation for low high-density lipoprotein (HDL) cholesterol levels. It was found that patient had persistently low HDL cholesterol (<10 mg/dl) and persistently high serum triglycerides (>200 mg/dl) on multiple occasions. The patient was nonobese, nonsmoker, and had no other addictions. He had no history of premature cardiovascular events or renal failure in the family. Patient's fasting blood sugars, renal function tests, and urine analysis were normal. This mystery of persistent hypoalphalipoproteinemia was solved when it was noticed that patient had bilateral corneal opacities [Figure 1]. Ophthalmologic evaluation revealed corneal opacities involving all the layers of the cornea with maximum density near the limbus, without any impairment of vision.
Figure 1

Corneal opacities

Corneal opacities Persistent hypoalphalipoproteinemia with characteristic corneal opacities led to the provisional diagnosis of fish eye disease. Plasma lecithin- cholesterol acyltransferase (LCAT) activity performed at Pacific Biomarkers, USA, was normal. Genetic studies could not be performed because of economic non-viability. Family members had no dyslipidemia or corneal opacities. Fish eye disease is a rare disease with only about thirty case reports.[2] Fish eye disease or partial LCAT deficiency was named after the appearance of cornea similar to that of boiled fish.[3] There is a partial deficiency of alpha-LCAT activity (present in HDL) while beta-LCAT activity is preserved.[4] In contrast to total LCAT deficiency, fish eye disease patients have no anemia or renal failure. There is no risk for premature coronary artery disease.[5] The patient was reassured and advised to follow-up with ophthalmologists at regular intervals.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.

Authors:  L A Carlson; B Philipson
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

Review 2.  Familial LCAT deficiency and fish-eye disease.

Authors:  N McIntyre
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

3.  Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.

Authors:  Laura Calabresi; Damiano Baldassarre; Samuela Castelnuovo; Paola Conca; Letizia Bocchi; Chiara Candini; Beatrice Frigerio; Mauro Amato; Cesare R Sirtori; Paola Alessandrini; Marcello Arca; Giuliano Boscutti; Luigi Cattin; Loreto Gesualdo; Tiziana Sampietro; Gaetano Vaudo; Fabrizio Veglia; Sebastiano Calandra; Guido Franceschini
Journal:  Circulation       Date:  2009-08-18       Impact factor: 29.690

4.  Co-existence of classic familial lecithin-cholesterol acyl transferase deficiency and fish eye disease in the same family.

Authors:  H S Mahapatra; S Ramanarayanan; A Gupta; M Bhardwaj
Journal:  Indian J Nephrol       Date:  2015 Nov-Dec
  4 in total
  1 in total

Review 1.  A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.

Authors:  Cecilia Vitali; Archna Bajaj; Christina Nguyen; Jill Schnall; Jinbo Chen; Kostas Stylianou; Daniel J Rader; Marina Cuchel
Journal:  J Lipid Res       Date:  2022-01-20       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.